ACIU
#3407
AC Immune SA - Common Stock
2.6 7 USD
-0.01%
Market Price
Settore: Salute
Base: USD
Valuta di Profitto: USD
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
-1.48%
Variazione Mensile
+16.59%
Variazione di 6 mesi
-5.65%
Variazione Annuale
+29.61%
Chiusura Precedente
2.7 1
Open
2.6 9
Minimo
2.6 6
Massimo
2.7 0
Volume
38
Financials
- Market Capitalization 271.65 M
- Employee 122
- Founded 2003
- CEO Andrea Pfeifer
- Website www.acimmune.com
- Headquarter Switzerland
- FIGI UNKNOWN
- Industry Biotecnologia
Related tickers
| # | Nome | Prezzo | 24h % | 7d % | 1M % | 1Y % | Valore di Mercato | Ultimi 7 Giorni | |
|---|---|---|---|---|---|---|---|---|---|
| 3387 |  ALXO ALX Oncology Holdings Inc. - Common Stock | 2.00 USD | -2.44% | -1.96% | +1.52% | +75.44% | 276.55 M USD | ||
| 3396 |  AVXL Anavex Life Sciences Corp. - Common Stock | 2.98 USD | -4.79% | -8.02% | +16.41% | -67.61% | 276.16 M USD | ||
| 3411 |  TRDA Entrada Therapeutics, Inc. - Common Stock | 6.98 USD | -3.99% | -7.06% | +20.76% | +0.14% | 271.78 M USD | ||
| 3418 |  NMRA Neumora Therapeutics, Inc. - Common Stock | 1.39 USD | -6.08% | -14.72% | -17.75% | -20.57% | 261.18 M USD |